Eris Lifesciences Ltd vs Fdc Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1402 as of 12 Jun 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of FDC Ltd changed from 16 on March 2021 to 24.1 on March 2025 . This represents a CAGR of 8.54% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of FDC Ltd changed from ₹ 4822 crore on March 2021 to ₹ 6419 crore on March 2025 . This represents a CAGR of 5.89% over 5 years The revenue of ERIS Lifesciences Ltd for the Mar '26 is ₹ 758.79 crore as compare to the Dec '25 revenue of ₹ 807.59 crore. This represent the decline of -6.04% The revenue of FDC Ltd for the Mar '26 is ₹ 634.68 crore as compare to the Dec '25 revenue of ₹ 485.51 crore. This represent the growth of 30.72% The ebitda of ERIS Lifesciences Ltd for the Mar '26 is ₹ 274.6 crore as compare to the Dec '25 ebitda of ₹ 264.51 crore. This represent the growth of 3.81% The ebitda of FDC Ltd for the Mar '26 is ₹ 156.25 crore as compare to the Dec '25 ebitda of ₹ 52.29 crore. This represent the growth of 198.81% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 279.1 crore over 8 quarters. This represents a CAGR of 76.54% The net profit of FDC Ltd changed from ₹ 119.04 crore to ₹ 103.4 crore over 8 quarters. This represents a CAGR of -6.80% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of FDC Ltd changed from 29.75 % on March 2025 to 29.75 % on March 2025 . This represents a CAGR of 0.00% over 1 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About FDC Ltd

FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

FAQs for the comparison of ERIS Lifesciences Ltd and FDC Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or FDC Ltd?

Market cap of ERIS Lifesciences Ltd is 19,439 Cr while Market cap of FDC Ltd is 6,315 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and FDC Ltd?

The stock performance of ERIS Lifesciences Ltd and FDC Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and FDC Ltd?

As of June 14, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1402.9. On the other hand, FDC Ltd stock price is INR ₹387.9.

How do dividend payouts of ERIS Lifesciences Ltd and FDC Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and FDC Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.